Prof. Joyce Tait
Founding Director of the Innogen Centre/Institute
Contact details
- Tel: +44 (0) 131 650 9174
- Email: joyce.tait@ed.ac.uk
Address
- Street
-
Global Academy of Agriculture and Food Systems
The University of Edinburgh
Easter Bush Campus - City
- Midlothian
- Post code
- EH25 9RG
Background
I have an interdisciplinary background, covering natural and social sciences and have specialised in user-focused approaches to complex issues in the contexts of innovation, risk governance and stakeholder engagement in the following areas:
- strategic and management decision making in companies and public bodies
- agricultural and health-related applications of life sciences
- policy analysis, risk assessment and regulation
- stakeholder attitudes, science and risk communication
- evaluation and application of interdisciplinary research
- sustainable development
Research Projects
-
Creating an innovation ecosystem for rapid diagnostic tests for livestock to support sustainable antibiotic use
In:
Technology Analysis and Strategic Management
DOI: https://doi.org/10.1080/09537325.2021.1950678
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Responsible innovation: Its role in an era of technological and regulatory transformation
(7 pages)
In:
Engineering Biology, vol. 5, pp. 2-9
DOI: https://doi.org/10.1049/enb2.12005
Research output: Contribution to Journal › Article (Published) -
Political influences on biotechnology-based innovation for European agriculture: Risk-assessment and risk management
(12 pages)
In:
Technology Analysis and Strategic Management, vol. 33, pp. 271-282
DOI: https://doi.org/10.1080/09537325.2019.1573983
Research output: Contribution to Journal › Article (Published) -
Regulatory and market influences on innovation pathways for the development of new antimicrobial drugs
(13 pages)
In:
Technology Analysis and Strategic Management, vol. 33, pp. 283-295
DOI: https://doi.org/10.1080/09537325.2019.1634253
Research output: Contribution to Journal › Article (Published) -
Policy support for disruptive innovation in the life sciences
(13 pages)
In:
Technology Analysis and Strategic Management, vol. 33, pp. 307-319
DOI: https://doi.org/10.1080/09537325.2019.1631449
Research output: Contribution to Journal › Article (Published) -
Understanding the emergence and evolution of new business models in the UK regenerative medicine sector
(14 pages)
In:
Technology Analysis and Strategic Management, vol. 33, pp. 320-333
DOI: https://doi.org/10.1080/09537325.2019.1685087
Research output: Contribution to Journal › Article (Published) -
Regenerative medicine as a disruptive technology: Implications for manufacturing and clinical adoption
(17 pages)
In:
Cell and Gene Therapy Insights, vol. 5, pp. 1287-1303
DOI: https://doi.org/10.18609/cgti.2019.135
Research output: Contribution to Journal › Article (Published) -
Beyond the limits to governance: New rules of engagement for the tentative governance of the life sciences
In:
Research Policy, vol. 48, pp. 1128-1137
DOI: https://doi.org/10.1016/j.respol.2019.01.009
Research output: Contribution to Journal › Article (Published) -
Diagnostic technologies and antimicrobial use in livestock systems
(2 pages)
In:
Veterinary Record, vol. 183, pp. 626-627
DOI: https://doi.org/10.1136/vr.k4913
Research output: Contribution to Journal › Letter (Published) -
Evolution of regenerative medicine business models: Ecosystem effects on a disruptive innovation
In:
Clinical Therapeutics, vol. 40, pp. 1084-1094
DOI: https://doi.org/10.1016/j.clinthera.2018.06.003
Research output: Contribution to Journal › Article (Published)